郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Evidence that extracellular anions interact with a site outside the CFTR chloride channel pore to modify channel properties.

期刊：Canadian journal of physiology and pharmacology发表年份：2009作者：Jing-Jun Zhou; Paul Linsdell
阅读更多 →

药效评价The molecular target of rubimaillin in the inhibition of lipid droplet accumulation in macrophages.

期刊：Biological & pharmaceutical bulletin发表年份：2009作者：Daisuke Matsuda; Taichi Ohshiro; Mio Ohba; Wei Jiang; Bin Hong; Shuyi Si; Hiroshi Tomoda
阅读更多 →

药效评价Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist.

期刊：Journal of medicinal chemistry发表年份：2009作者：Fumihito Muro; Shin Iimura; Yuuichi Sugimoto; Yoshiyuki Yoneda; Jun Chiba; Toshiyuki Watanabe; Masaki Setoguchi; Yutaka Iigou; Keiko Matsumoto; Atsushi Satoh; Gensuke Takayama; Tomoe Taira; Mika Yokoyama; Tohru Takashi; Atsushi Nakayama; Nobuo Machin
阅读更多 →

药效评价Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag.

期刊：Proceedings of the National Academy of Sciences of the United States of America发表年份：2009作者：Peng Wu; Wenqing Shui; Brian L Carlson; Nancy Hu; David Rabuka; Julia Lee; Carolyn R Bertozzi
阅读更多 →